Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824206) titled 'Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Future Options Research, LLC

Condition: Blunted Emotion in Major Depressive Disorder

Intervention: Drug: lumateparone 42 mg once daily

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 2026

Target Sample Size: 30

Countries of Recruitment: United States

To know mo...